SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending following the FDA approval of its Wegovy pill, marking a significant milestone as the first oral GLP-1 therapy for weight management. The community is buzzing with excitement, viewing this as a "game changer" that could vastly expand market access by offering a convenient alternative to injections. Many anticipate a substantial upward revaluation and a potential short squeeze, arguing the stock has been significantly undervalued relative to its sector peers.

Starfighters Space Inc

Starfighters Space Inc. (FJET) is trending due to its explosive post-IPO gains, fueled by its low public float and intense speculative interest in the aerospace sector. Community chatter is highly polarized, with many celebrating its "parabolic" ascent and comparing it to past runners, while others caution it's an overhyped "pump and dump" given its limited operational history and fundamental concerns. This stark debate highlights the stock's significant volatility and high investor attention.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is trending due to recent exploration drill results indicating high-grade silver in its Vortex system, significantly expanding the perceived value of its vast deposits. This news is driving community discussion around potential for a substantial short squeeze, robust institutional interest from major investors like Eric Sprott, and the broader tailwind of increasing gold and silver prices. While many are optimistic about the company's long-term prospects as a debt-free entity with considerable resources, some express caution regarding its lack of current revenue and highly elevated technical indicators.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending, fueled by its highly engaged community's belief in the "OG meme" and its lore, with many declaring it "extremely undervalued" and destined for billions. The community is actively building, expanding its presence across web3 and gaming platforms, solidifying conviction for long-term growth.

Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.

Niagen Bioscience Inc.

Niagen Bioscience (NAGE) is a focal point of market conversation, driven by anticipation for results from its NOPARK trial in Parkinson's disease and other clinical studies, along with expanding Niagen+ offerings. The community is actively debating the company's significant growth potential, eyeing strategic pharmaceutical partnerships and the impact of strong financial performance on its perceived undervaluation in the burgeoning NAD+ market.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is generating significant buzz due to its amended, all-cash takeover offer for Warner Bros. Discovery, now fortified by a substantial personal guarantee from Larry Ellison. This move has ignited community discussion, with many viewing PSKY's bid as a superior path to shareholder value compared to rival proposals, potentially impacting the broader media streaming market.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is actively discussed following recent financing secured from Macquarie, which the community views as strong validation for new data center projects. This funding fuels speculation about an impending hyperscaler lease, with significant conversation around potential new sites and the company's strategic positioning within the surging AI infrastructure market.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM Integrated Shipping is trending as its board rejected a CEO-led buyout offer, confirming receipt of multiple acquisition proposals and initiating a strategic review aimed at maximizing shareholder value. The community is actively discussing a potential bidding war, highlighting the company's substantial cash reserves and book value, which many believe indicate the stock is severely undervalued. This dynamic, coupled with high short interest, is fueling expectations for a much higher acquisition price.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is trending following pivotal progress and new positive clinical data for its gene therapies, particularly RGX-202 for Duchenne muscular dystrophy and RGX-121 for Hunter syndrome. The community is actively discussing the potential for these programs to be best-in-class and highly undervalued, especially in light of a new strategic commercialization partnership and strong analyst sentiment. Investors are keenly anticipating upcoming regulatory milestones and further pipeline advancements in the gene therapy space, despite recent market fluctuations.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is trending following a recent reverse stock split and evolving updates on its fingerprint drug screening technology. Community discussions are heavily focused on renewed delays in FDA clearance, which now involves additional clinical studies, alongside ongoing concerns regarding potential dilution. Despite these hurdles, many investors remain optimistic about the company's global product adoption and its long-term potential in the lucrative U.S. market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ENDRAs TAEUS Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use

ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or the Company), a pioneer in thermo-acoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), today announced new...

ENDRA Feasibility Study Demonstrates TAEUS Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker

ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or the Company), a pioneer in biomarker imaging technologies for the early detection and monitoring of metabolic dysfunction-associated liver disease...

ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results

ENDRA Life Sciences Inc. (Nasdaq: NDRA) (ENDRA or the Company), a pioneer in biomarker imaging technologies for the early detection and monitoring of metabolic dysfunction associated liver disease...

ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCA

ENDRA Life Sciences Inc. (Nasdaq: NDRA) (ENDRA or the Company), a pioneer in imaging technologies for the early detection and monitoring of metabolic dysfunction associated liver disease (MASLD) and...

ENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token Holdings

Merit Medical Expands GI Portfolio With $22M C2 CryoBalloon Acquisition

MMSI is set to acquire C2 CryoBalloon from Pentax for $22M, strengthening its GI portfolio. Despite near-term dilution, the deal positions Merit for long-term growth in gastroenterology.

ENDRA Life Sciences (NDRA) on Monday announced an aggregate of $4.9 million in commitments for a private placement, which was led by institutional and cryptocurrency investors.The investors have agreed to buy 744,340 shares of common stock or prefunded warrants, and accompanying warrants under the agreement, Endra said. If all warrants are fully exercised for cash, the company will receive up to $14.4 million in proceeds, it said. The offering is expected to close on or about October 14. &nbsp;The proceeds of the placement will be used to launch a digital asset treasury strategy managed by digital asset manager Arca Investment Management, the company said. ENDRA also intends to accumulate cryptocurrency and complete the TAEUS pilot validation imaging study focused on certain chronic liver conditions. Thermo Acoustic Enhanced UltraSound, or TAEUS, is a technology being developed by the company to assess tissue fat content and monitor tissue ablation during minimally invasive procedures.The company also <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.businesswire.com/news/home/20251013346843/en/ENDRA-Life-Sciences-Announces-At-Market-Private-Placement-of-Up-to-%2414.4-Million-to-Launch-Digital-Asset-Treasury-Strategy-Managed-by-Leading-Crypto-Asset-Manager-Arca">announced</a> on Monday that it intends to add Arca’s Chief Investment Officer, Jeff Dorman, to its Digital Asset Advisory Board. The firm believes its new digital asset treasury strategy can compound returns and create flexible income to reinvest into cryptocurrency.<a href="https://stocktwits.com/symbol/NDRA">NDRA shares</a> traded 24% higher at the time of writing. On Stocktwits, retail sentiment around the stock rose from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘high’ to ‘extremely high’ levels.NDRA stock is up by 28% this year and by 10% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-tvardi-therapeutics-stock-plummet-pre-market/ch6SK9gR3ki">Why Did Tvardi Therapeutics Stock Plummet 87% Pre-Market Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

What’s Driving The Rally In NDRA Stock Today?

The company announced $4.9 million in commitments for a private placement led by institutional and cryptocurrency investors to be used to launch a digital asset treasury strategy.

Equity

The company announced $4.9 million in commitments for a private placement led by institutional and cryptocurrency investors to be used to launch a digital asset treasury strategy.


Pulse Biosciences Unveils Promising First-in-Human Data for nPulse

PLSE unveils strong first-in-human data for its nPulse Cardiac Surgical System, showcasing safety, speed, and durable AF treatment potential.

ENDRA Life Sciences Announces At-Market Private Placement of Up to $14.4 Million to Launch Digital Asset Treasury Strategy Managed by Leading Crypto Asset Manager Arca

ENDRA Life Sciences, Inc. engages in the development of medical devices for accurate liver fat measurement for use in metabolic disease detection and GLP-1 drug eligibility and management. The company was founded on July 18, 2007 and is headquartered in Ann Arbor, MI.

NDRA
ENDRA Life Sciences Inc

Feed

News

Sentiment

Fundamentals

Info

Latest NDRA News

NDRAENDRA Life Sciences Inc